Table 1 Baseline characteristics in both groups (< vs. ≥ 50 years).
From: Effect of age on clinical impact and mid-term denervation in patients undergoing cardioneuroablation
< 50 years (n = 17) | ≥ 50 years (n = 33) | p-value | |
|---|---|---|---|
Age (years) | 42.8 ± 6.5 | 61.8 ± 9.7 | < 0.001 |
Women, n (%) | 8 (47.1) | 7 (21.2) | 0.059 |
Hypertension, n (%) | 0 (0) | 16 (48.5) | < 0.001 |
Diabetes, n (%) | 0 (0) | 6 (18.2) | 0.061 |
AF, n (%) | 0 (0) | 2 (6.1%) | 0.542 |
Indication: n (%) | |||
SND | 0 (0) | 11 (33.3) | 0.026 |
AVB | 5 (29.4) | 6 (18.2) | |
VVS | 12 (70.6) | 16 (48.5) | |
CS hypersensitivity, n (%) | 2 (11.8) | 14 (42.4) | 0.028 |
Pause > 6 seg (CSD), n (%) | 0 (0) | 12 (36.4) | 0.004 |
Syncope, n (%) | 15 (88.2) | 28 (84.9) | 0.744 |
Syncope/year | 4.1 (1.2–13.9) | 2.1 (0.8–16.6) | 0.476 |
Presyncope, n (%) | 16 (94.1) | 33 (100) | 0.159 |
Asthenia, n (%) | 1 (5.9) | 10 (30.3) | 0.07 |
LVEF (%) | 61.9 ± 3.6 | 63.1 ± 5.1 | 0.433 |
Sinus pause, n (%) | 9 (52.9) | 17 (51.5) | 1.000 |
Sinus bradycardia, n (%) | 6 (35.3) | 21 (63.6) | 0.057 |
Nodal rhythm, n (%) | 1 (5.9) | 8 (24.2) | 0.109 |
ILR monitoring, n (%) | 11 (64.7) | 15 (45.5) | 0.412 |
Number of pauses on loop recording pre-CNA per year | 4.0 (2.2–18.9) | 3.2 (1.5–11.4) | 0.441 |
HR basal ECG (bpm) | 63.5 ± 13.3 | 62.5 ± 16.9 | 0.831 |
Low voltage area LA, n (%) | 0 (0) | 6 (18.2) | 0.061 |
Low voltage area RA, n (%) | 0 (0) | 6 (18.2) | 0.061 |
